150 related articles for article (PubMed ID: 88679)
1. Suppression and reversal of allergic encephalomyelitis in rhesus monkeys with basic protein and peptides.
Eylar EH; Jackson JJ; Kniskern PJ
Neurochem Res; 1979 Apr; 4(2):249-58. PubMed ID: 88679
[TBL] [Abstract][Full Text] [Related]
2. The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
Keith AB; Arnon R; Teitelbaum D; Caspary EA; Wisniewski HM
J Neurol Sci; 1979 Jul; 42(2):267-74. PubMed ID: 90129
[TBL] [Abstract][Full Text] [Related]
3. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
Hofstetter HH; Shive CL; Forsthuber TG
J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
[TBL] [Abstract][Full Text] [Related]
4. Participation of encephalitogen in incomplete Freund's adjuvant in the induction of experimental allergic encephalomyelitis in Hartley guinea pigs.
Lebar R; Vincent C
J Neuroimmunol; 1984 Jun; 6(3):187-96. PubMed ID: 6202714
[TBL] [Abstract][Full Text] [Related]
5. Rhesus diploid rabies vaccine (adsorbed): neurological safety in guinea pigs and Lewis rats.
Levenbook IS; Elisberg BL; Driscoll BF
Vaccine; 1986 Dec; 4(4):225-7. PubMed ID: 2432737
[TBL] [Abstract][Full Text] [Related]
6. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides.
Falk K; Rötzschke O; Santambrogio L; Dorf ME; Brosnan C; Strominger JL
J Exp Med; 2000 Feb; 191(4):717-30. PubMed ID: 10684863
[TBL] [Abstract][Full Text] [Related]
7. Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats.
Keith AB
J Neurol Sci; 1978 Oct; 38(3):317-26. PubMed ID: 569689
[TBL] [Abstract][Full Text] [Related]
8. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
Jagessar SA; Heijmans N; Blezer EL; Bauer J; Weissert R; 't Hart BA
J Neuroinflammation; 2015 Sep; 12():169. PubMed ID: 26377397
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of relapsing experimental allergic encephalomyelitis.
Lublin FD
Neurology; 1984 Dec; 34(12):1615-7. PubMed ID: 6209597
[TBL] [Abstract][Full Text] [Related]
10. [Induction of experimental allergic encephalomyelitis with encephalitogenic myelin proteins from the spinal cord of a bull].
Pleskov VM; Saakian IL; Zhitnukhin IuL
Vopr Med Khim; 1979; 25(4):420-3. PubMed ID: 473681
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental allergic encephalomyelitis by the encephalitogenic peptide, in solution or bound to liposomes.
Avrilionis K; Boggs JM
J Neuroimmunol; 1991 Dec; 35(1-3):201-10. PubMed ID: 1720133
[TBL] [Abstract][Full Text] [Related]
12. Experimental allergic encephalomyelitis in guinea pigs. Influence of thymosin fraction V on the disease.
Woyciechowska J; Goldstein AL; Driscoll B
J Neuroimmunol; 1985 Jan; 7(4):215-9. PubMed ID: 2578135
[TBL] [Abstract][Full Text] [Related]
13. Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys.
Alvord EC; Shaw CM; Hruby S
Ann Neurol; 1979 Dec; 6(6):469-73. PubMed ID: 93874
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
15. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis.
Raine CS; Traugott U; Stone SH
Science; 1978 Aug; 201(4354):445-8. PubMed ID: 78524
[TBL] [Abstract][Full Text] [Related]
16. Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide.
Hoffman PM; Gaston DD; Spitler LE
Clin Immunol Immunopathol; 1973 Apr; 1(3):364-71. PubMed ID: 4127172
[No Abstract] [Full Text] [Related]
17. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
18. Chronic progressive experimental allergic encephalomyelitis (EAE) in adult guinea pigs.
Wisniewski HM; Madrid RE
J Neuropathol Exp Neurol; 1983 May; 42(3):243-55. PubMed ID: 6188808
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
20. Neural antigens and induction of myelination inhibition factor.
Seil FJ; Kies MW; Bacon M
J Immunol; 1975 Feb; 114(2 Pt 1):630-4. PubMed ID: 47359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
